CMIC's CRO segment provides comprehensive clinical trial services, including clinical operations, data management, medical writing, patient recruitment, and pharmacovigilance. They utilize advanced technologies for data analysis and management, ensuring the integrity and efficiency of clinical trials. This segment focuses on supporting drug development across various therapeutic areas, with a strong emphasis on oncology and orphan drug development. CMIC's market positioning is as a leading CRO in Japan, offering a wide range of services and a strong network of clinical sites. Future opportunities include expanding into decentralized clinical trials and leveraging AI for improved trial design and execution. Regulatory compliance and adherence to GCP guidelines are critical aspects of this segment, ensuring the safety and efficacy of clinical trials. Partnerships with technology providers and research institutions further enhance their capabilities.

The CDMO segment offers comprehensive development and manufacturing services, including formulation, process development, analytical development, and commercial supply. CMIC provides investigational product manufacturing, packaging, labeling, and release and stability tests. They utilize advanced manufacturing technologies and adhere to GMP standards. This segment supports the development and production of pharmaceuticals across various therapeutic areas, with a focus on ensuring product quality and timely delivery. CMIC's market position is as a reliable CDMO partner, offering integrated solutions from development to commercialization. Future opportunities include expanding manufacturing capacity and capabilities to support the growing demand for complex drug products. Regulatory compliance, including FDA and other international standards, is a key focus. Partnerships with pharmaceutical companies and technology providers are essential for innovation and growth.

CMIC's CSO segment provides sales and marketing services to pharmaceutical companies, including sales force deployment, marketing strategy development, and product promotion. They leverage data analytics and market research to optimize sales efforts and ensure effective market access. This segment focuses on supporting the commercialization of pharmaceutical products across various therapeutic areas. CMIC's market positioning is as a trusted CSO partner, offering a skilled sales force and comprehensive marketing support. Future opportunities include expanding into new markets and leveraging digital marketing technologies. Regulatory compliance and ethical promotion practices are critical aspects of this segment. Partnerships with pharmaceutical companies are essential for driving product sales and market share.

This segment encompasses patient and healthcare services, including drug adherence support programs, prescription drug databases, and consulting services. CMIC offers services such as post-marketing surveillance, regulatory affairs consulting, and product life cycle management. They utilize digital health technologies and data analytics to improve patient outcomes and support healthcare providers. This segment focuses on improving patient care and supporting the development of innovative therapies. CMIC's market positioning is as a provider of integrated healthcare solutions, offering a range of services from clinical trials to patient support. Future opportunities include expanding into telemedicine and personalized medicine. Regulatory compliance and data privacy are critical aspects of this segment. Partnerships with healthcare providers, technology companies, and pharmaceutical companies are essential for innovation and growth.